s6y

3 CUMBERLAND PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001209191-22-043130

Documents

  1. FORM 3 SUBMISSION 3
  2. POA DOCUMENT EX-24

On sec.gov